Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 35 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 9649373

    Neoseptins: small molecule adjuvants

    The Board of Regents of the University of Texas System · Granted May 16, 2017 · Expires May 11, 2037

    granted

  2. US 9649344

    Methods and compositions for in vivo induction of pancreatic beta cell formation

    The Board of Regents of the University of Texas System · Granted May 16, 2017 · Expires May 11, 2037

    granted

  3. US 9642859

    Use of capsazepine and analogs thereof to treat cancer

    The Board of Regents of the University of Texas System · Granted May 9, 2017 · Expires May 4, 2037

    granted

  4. US 9645139

    Neuroprotective chemicals and methods for identifying and using same

    The Board of Regents of the University of Texas System · Granted May 9, 2017 · Expires May 4, 2037

    granted

  5. US 9638639

    Plasmonic-magnetic bifunctional nanotubes for biological applications

    The Board of Regents of the University of Texas System · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

  6. US 9629877

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  7. US 9630990

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  8. US 9631041

    PH-sensitive compositions for delivery of beta lapachone and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  9. US 9624484

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  10. US 9624211

    Anti-cancer compounds

    The Board of Regents of the University of Texas System · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  11. US 9616048

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  12. US 9616076

    Methods for treating viral infections using hydrogen sulfide donors

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  13. US 9618521

    Sperm-specific cation channel, Catsper2, and uses therefor

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  14. US 9617511

    Tissue-specific differentiation matrices and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  15. US 9611266

    Compounds and anti-tumor NQO1 substrates

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  16. US 9611292

    Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  17. US 9605057

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  18. US 9598694

    Micro-RNAs involved in macular degeneration

    The Board of Regents of the University of Texas System · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  19. US 9593131

    Copper-cysteamine and methods of use

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  20. US 9592238

    Anti-ceramide monoclonal antibody 2A2

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  21. US 9585910

    Polymers functionalized with ion-specific recognition elements

    The Board of Regents of the University of Texas System · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted

  22. US 9580690

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  23. US 9579370

    Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination

    The Board of Regents of the University of Texas System · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  24. US 9572828

    Treatment for melanoma

    The Board of Regents of the University of Texas System · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.